Therefore, the role of GLP-1 RAs specifically in the cardiovascular system has been of particular interest in the past several years, and multiple clinical trials have examined the cardiovascular effects and safety of GLP-1 RAs (Table 1)
The pattern of lower weight loss in a diabetic population than a non-diabetic one is consistent with everything seen with semaglutide and tirzepatide, and is expected rather than disappointing
Although you should by now have noticed some changes in weight, its not uncommon for people to experience minimal weight loss while their body adjusts to the new routine
Sustainable weight loss combines medication, dietary changes, exercise, and ongoing medical support.
While there are strong competitors and market leaders in the digital obesity and weight loss segment, partnerships with those may entail longer negotiation periods to align strategic goals and expectations, leading to several challenges to overcome in terms of costs and flexibility